Cardiogen
Cardiogen (Ala-Glu-Asp-Arg) — short cardiac-tissue peptide bioregulator for myocardial cell, cardiovascular aging, and heart-tissue repair research
Select size
For research purposes only. Not for human consumption.
Mechanism of Action
Cardiogen is a short synthetic peptide bioregulator (tetrapeptide Ala-Glu-Asp-Arg) developed within the Khavinson family of peptide bioregulators. It is studied for tissue-specific gene expression in cardiac myocytes, where it is proposed to modulate transcription factors involved in cardiomyocyte differentiation, mitochondrial function, and connective-tissue remodeling of the heart.
How It Works
- 1
Enters cardiac cell nuclei and interacts with promoter regions of cardiomyocyte-associated genes
- 2
Modulates expression of transcription factors linked to myocardial cell differentiation and repair
- 3
Supports mitochondrial density and oxidative capacity in aged cardiac tissue models
- 4
Studied for attenuating age-related fibrosis and preserving contractile-protein expression
- 5
Investigated alongside other Khavinson peptides for tissue-specific regenerative research
Key Research Benefits
- Cardiac tissue and cardiomyocyte research
- Cardiovascular aging model studies
- Myocardial gene-expression investigation
- Mitochondrial and oxidative capacity research
- Complementary probe alongside SS-31 and Epithalon
Cardiogen belongs to the Khavinson short peptide bioregulator class studied primarily in Russian and Eastern European gerontology literature. Each vial contains 20mg of lyophilized peptide. Reconstitute with bacteriostatic water and store refrigerated (2–8°C) post-reconstitution. For research use only — not for human consumption.